Profile of blonanserin for the treatment of schizophrenia

Tomomi Tenjin, Seiya Miyamoto, Yuriko Ninomiya, Rei Kitajima, Shin Ogino, Nobumi Miyake, Noboru YamaguchiDepartment of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Kanagawa, JapanAbstract: Blonanserin was developed as an antipsychotic drug in Japan and approved for the treat...

Full description

Bibliographic Details
Main Authors: Tenjin T, Miyamoto S, Ninomiya Y, Kitajima R, Ogino S, Miyake N, Yamaguchi N
Format: Article
Language:English
Published: Dove Medical Press 2013-04-01
Series:Neuropsychiatric Disease and Treatment
Online Access:http://www.dovepress.com/profile-of-blonanserin-for-the-treatment-of-schizophrenia-a12902